| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, February 2001, p. 707-718, Vol. 80, No. 2
The Salk Institute for Biological Studies, Peptide Biology Lab, La Jolla, California 92037 USA
| |
ABSTRACT |
|---|
|
|
|---|
The weaver mutation (G156S) in G-protein-gated inwardly rectifying K+ (GIRK) channels alters ion selectivity and reveals sensitivity to inhibition by a charged local anesthetic, QX-314, applied extracellularly. In this paper, disrupting the ion selectivity in another GIRK channel, chimera I1G1(M), generates a GIRK channel that is also inhibited by extracellular local anesthetics. I1G1(M) is a chimera of IRK1 (G-protein-insensitive) and GIRK1 and contains the hydrophobic domains (M1-pore-loop-M2) of GIRK1 (G1(M)) with the N- and C-terminal domains of IRK1 (I1). The local anesthetic binding site in I1G1(M) is indistinguishable from that in GIRK2wv channels. Whereas chimera I1G1(M) loses K+ selectivity, although there are no mutations in the pore-loop complex, chimera I1G2(M), which contains the hydrophobic domain from GIRK2, exhibits normal K+ selectivity. Mutation of two amino acids that are unique in the pore-loop complex of GIRK1 (F137S and A143T) restores K+ selectivity and eliminates the inhibition by extracellular local anesthetics, suggesting that the pore-loop complex prevents QX-314 from reaching the intrapore site. Alanine mutations in the extracellular half of the M2 transmembrane domain alter QX-314 inhibition, indicating the M2 forms part of the intrapore binding site. Finally, the inhibition of G-protein-activated currents by intracellular QX-314 appears to be different from that observed in nonselective GIRK channels. The results suggest that inward rectifiers contain an intrapore-binding site for local anesthetic that is normally inaccessible from extracellular charged local anesthetics.
| |
INTRODUCTION |
|---|
|
|
|---|
Many inhibitory neurotransmitters exert their
actions, in part, by stimulating G-protein-coupled neurotransmitter
receptors and activating G-protein-gated inwardly rectifying
K+ (GIRK) channels (Hille, 1992
; Nicoll et al.,
1990
; North, 1989
). Near the cell's resting membrane potential, a
small efflux of K+ ions flows through GIRK
channels and reduces membrane excitability (Hille, 1992
). GIRK channels
are expressed in a variety of cell types, including cardiac, brain, and
endocrine tissues (Doupnik et al., 1995
). In the heart, parasympathetic
activation slows the heart rate by opening atrial muscarinic GIRK
channels (Harris and Hutter, 1956
; Trautwein and Dudel, 1958
). In the
brain, GIRK channels are postulated to be an important regulator of
neuronal membrane excitability. Mutant mice that lack GIRK2 channels
and GABAB receptor-activated GIRK currents are
more susceptible to seizures (Signorini et al., 1997
; Slesinger et al.,
1997
).
Four different mammalian GIRK channels have been identified thus far,
GIRK1-GIRK4 (Kir3.1-Kir3.4) (Doupnik et al., 1995
). Although GIRK2,
GIRK3, and GIRK4 channel subunits form homomultimers in heterologous
expression systems (Duprat et al., 1995
; Kofuji et al., 1995
;
Krapivinsky et al., 1995a
; Velimirovic et al., 1996
), the GIRK1 subunit
does not appear to form homomultimers (Hedin et al., 1996
). In
Xenopus oocytes, GIRK1 co-assembles with an endogenous GIRK
subunit, XIR, to form functional heteromultimers on the membrane
surface (Hedin et al., 1996
), whereas in mammalian cells, GIRK1
subunits fail to express on the membrane surface (Kennedy et al., 1996
;
Philipson et al., 1995
). By contrast, expression of GIRK2 cRNA in
Xenopus oocytes gives rise to large basal and G-protein-activated inwardly rectifying K+
currents, indicating that GIRK2 channels form homomultimers (Kofuji et
al., 1995
; Lesage et al., 1995
; Slesinger et al., 1996
). GIRK channels
are opened by the direct interaction of G protein
G
subunits with the
N- and C-terminal domains of GIRK (Huang et al., 1995
; Inanobe et al.,
1995
; Krapivinsky et al., 1995b
; Kunkel and Peralta, 1995
). In addition
to the cytoplasmic N- and C-terminal domains, GIRK channels possess two
putative membrane-spanning domains (M1 and M2) (Kubo et al., 1993
) and
a highly conserved pore-loop complex that is involved in ion
selectivity (Kofuji et al., 1996b
; Slesinger et al., 1996
).
In the developmentally impaired weaver mouse, a
glycine-to-serine mutation was identified in the pore-loop complex of
GIRK2 (G156S, referred to as GIRK2wv) (Patil et
al., 1995
). The G156S mutation disrupts the ion selectivity of GIRK2
channels (Kofuji et al., 1996b
; Slesinger et al., 1996
) and appears to
initiate the cellular changes that underlie the cell death observed in
weaver mouse cerebellum (Kofuji et al., 1996b
; Patil et al.,
1995
; Slesinger et al., 1997
). Surprisingly, GIRK2wv channels exhibit a sensitivity to
inhibition by externally applied QX-314, a permanently charged
derivative of the local anesthetic lidocaine (Kofuji et al., 1996b
).
Local anesthetics, however, are better known for their actions on
voltage-gated Na+ channels (Hille, 1992
). The
mechanism by which QX-314 inhibits GIRK2wv is not
well understood. A detailed electrophysiological characterization of
the QX-314 inhibition of GIRK2wv channels may
provide insights in the structure of inwardly rectifying K+ channels. Interestingly, intracellular
application of QX-314 has been reported to inhibit G-protein-gated
inwardly rectifying K+ currents in different
types of neurons (Alreja and Aghajanian, 1994
; Andrade, 1991
; Lambert
and Wilson, 1993
; Nathan et al., 1990
; Otis et al., 1993
; Yamada et
al., 1999
). These findings raise the possibility that GIRK channels
possess a single binding site for local anesthetics that is accessible
from the cytoplasmic side of the membrane for wild-type channels and
from the extracellular side of the membrane for nonselective channels.
In this paper, two different nonselective mutant GIRK channels,
GIRK2wv and I1G1(M), were used to study the role
of the ion selectivity filter in the inhibition produced by
extracellularly applied charged local anesthetics. In addition, the
inhibition of wild-type GIRK channels by intracellular QX-314 was
compared with that produced by extracellular QX-314 in nonselective
GIRK channels. Some of these results have been reported in abstract
form (Slesinger, 1999
).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Molecular biology
I1G1(M) (referred to previously as IGM); Slesinger
et al., 1995
) and GIRK2wv (Slesinger et al.,
1996
) cDNA constructs were made as described previously. Chimera
I1G1(M) contained amino acids 1-86 and 179-428 of IRK1 and 86-179 of
GIRK1. Chimera I1G2(M) was constructed using overlapping PCR and
contains amino acids 1-86 and 179-428 of IRK1 and 96-189 of GIRK2.
In some experiments, a hexahistidine-tagged GIRK1 was expressed with
GIRK4 in oocytes; the tag had no obvious effect on channel function.
Mutations in the pore-loop complex and M2 transmembrane domain were
constructed using the PCR overlap technique. The numbering nomenclature
for the mutants refers to the amino acid number in GIRK1. All
PCR-generated products were subjected to DNA sequencing (Salk
Sequencing Facility, La Jolla, CA) for potential errors generated by
Taq polymerase.
G
1 and
G
2 subunits were used as
described previously (Reuveny et al., 1994
). In vitro methyl-capped
cRNA was made using a T3 or T7 RNA polymerase kit (Epicentre, Madison,
WI). The concentration and quality of cRNA were estimated by separating
on an ethidium-stained formaldehyde gel and comparing with the RNA
molecular weight marker. Xenopus oocytes were isolated as
described previously (Slesinger et al., 1996
). Stage V/VI oocytes were
injected with a 46-nl solution containing cRNA for the G protein
G
1 (~2-8 ng) and
G
2 (~2-8 ng) subunits
and/or GIRK channels (0.5-5 ng). In some experiments, 13 ng of the
phosphothioated oligonucleotide XHA1 was co-injected with the cRNA to
suppress the expression of XIR (Hedin et al., 1996
). Oocytes were
incubated in 96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES (pH 7.6 with NaOH) for
2-7 days at 18°C.
Oocyte electrophysiology
Macroscopic currents were recorded from oocytes with a
two-electrode voltage-clamp amplifier (Geneclamp 500; Axon Instruments, Foster City, CA), filtered at 0.05-2 kHz, digitized (0.1-2 kHz) with
a Digidata 1200 A/D interface (Axon Instruments), and stored on a
laboratory computer. Electrodes were filled with 3 M KCl and had
resistances of 0.4-1 M
. Oocytes were perfused continuously with a
solution containing 90 mM XCl (X = K+,
Na+, or NMDG), 2 mM MgCl2,
and 10 mM HEPES (pH 7.5 with ~5 mM XOH or HCl for NMDG). QX-314 (RBI,
Ballwin, MO), QX-222 (Tocris, Natick, MA), and lidocaine (Sigma
Chemical Co., St. Louis, MO) were dissolved in
dH20 at a concentration of 40-50 mM and diluted
before each experiment. A small chamber (0.125 × 0.600 in) with
continuous, fast perfusion (5 ml/min) was used to change the
extracellular solutions and was connected to a virtual ground via a 3 M
KCl agarose bridge. For examining the effect of intracellular QX-314, 32.2 nl of 40 mM QX-314 dissolved in dH20 was
injected into oocytes 30-60 min before recording the currents for a
second time.
Analysis
For dose-response experiments, the data were normalized by
dividing the current in the presence of the drug by the current in the
absence of the drug (I/Io).
The normalized data were fit with the Hill equation (Eq. 1), where
Ki = the concentration at which
there is 50% inhibition and h = the Hill coefficient.
|
(1) |
For the study of mutant channels, the apparent
Ki was estimated using a variation of
the Hill equation (Eq. 2), where f = I/Io, [QX-314] = 100 µM, and h = Hill coefficient for wild-type channels
(0.855).
|
(2) |
|
(3) |
is the
equivalent electrical distance (z = 1 for QX-314), and
F, R, and T have their usual meaning
(Eq. 3). The equation assumes a negligible rate for QX-314 exiting into
the cytoplasm.
The permeability ratio
(PNa/PK)
was calculated (Eq. 4) from the shift in zero current potential
(
Erev) that occurred from changing
the extracellular solution from all K+ to all
Na+ (Hille, 1992
).
|
(4) |
| |
RESULTS |
|---|
|
|
|---|
Loss of K+ selectivity in I1G1(M) and GIRK2wv
Wild-type GIRK channels showed strong inward rectification and
exhibited high selectivity for K+ ions when
expressed in Xenopus oocytes. Macroscopic currents were
measured using two-electrode voltage clamp from oocytes injected with
the cRNA for GIRK1 and GIRK4 subunits and the G protein
G
1 and
G
2 subunits (Fig.
1 A). Under these conditions,
large inwardly rectifying currents were observed due to
G
activation of GIRK
channels (Reuveny et al., 1994
). To examine the
K+ selectivity, the macroscopic currents were
elicited by voltage steps from +50 mV to
100 mV in oocytes exposed to
an external solution containing all K+ and then
to one with all Na+. GIRK heteromultimers
composed of GIRK1 and GIRK4 subunits did not display any
Na+ current (Fig. 1 A). In
K+, note that the current-voltage plot shows
little outward current at potentials positive to 0 mV, indicative of
strong inward rectification (Fig. 1 A). As shown previously
(Slesinger et al., 1996
), substituting a serine for the glycine (G156S)
in the pore-loop complex of GIRK2 (GIRK2wv)
dramatically altered the K+ selectivity, allowing
Na+ to permeate the channel nearly equally as
well as K+ (Fig. 1 B).
|
Chimera I1G1(M) contains the GIRK1 hydrophobic core sequence, which
includes the M1, pore-loop complex and M2, and the N- and C-terminal
domains from IRK1 (Kir2.1), a G-protein-insensitive inwardly rectifying
K+ channel (Slesinger et al., 1995
). Oocytes
injected with the cRNA for I1G1(M) gave rise to large, basal inwardly
rectifying K+ currents (Fig. 1 C).
Surprisingly, I1G1(M) channels sustained a large
Na+ current. I1G1(M) channels showed inward
rectification but discriminated poorly among Na+
and K+ ions, like GIRK2wv
channels (Fig. 1, B and C). The
PK/PNa
permeability ratio was 0.76 ± 0.01 for I1G1(M) (N = 10), as compared with 0.78 ± 0.11 for
GIRK2wv (Slesinger et al., 1996
). By contrast,
I1G2(M), which has a hydrophobic core region
(M1-pore-loop-complex-M2) from GIRK2, exhibited normal K+ selectivity (Fig. 1 D). Thus, the
loss of K+ selectivity in I1G1(M) appeared to be
caused by amino acids in the GIRK1 channel (see below).
To examine whether nonselective channels were produced by the
co-assembly of I1G1(M) with the endogenous GIRK subunit XIR, the cRNA
for I1G1(M) was co-injected with an oligonucleotide antisense to XIR
(KHAI). KHAI was shown by Hedin et al. (1996)
to suppress the
expression of the XIR. I1G1(M) channels continued to form inwardly
rectifying and nonselective currents when co-expressed with KHAI (data
not shown). These results suggest that I1G1(M) channels form
homomultimers that lose K+ selectivity.
Inhibition of I1G1(M) and GIRK2wv channels by external QX-314
Kofuji et al. (1996)
reported that external application of QX-314
inhibited GIRK2wv channel activity when expressed
in Xenopus oocytes. Thus, I1G1(M) channels might also
exhibit sensitivity to externally applied QX-314. Several local
anesthetics, QX-314, QX-222, and lidocaine (Fig.
2 D), were examined for their
ability to inhibit I1G1(M) and GIRK2wv channels.
The macroscopic current was recorded continuously (at
80 mV) from
oocytes that were expressing I1G1(M) or GIRK2wv
channels (Fig. 2, A and B). Although these local
anesthetics differ in the size of the terminal amine group (Fig. 2
D), all three local anesthetics rapidly (less than 50 s) suppressed 30-70% of the inward K+ current.
No inward current was measured when all of the K+
was substituted with the large organic cation
N-methyl-D-glucamine (NMDG) (Fig. 2,
A and B). I1G1(M) and
GIRK2wv exhibited the same degree of inhibition
as well as rank order sensitivity to inhibition by 100 µM of each
local anesthetic (QX-314 > QX-222 > lidocaine; see Fig. 2
C). Co-expression of KHA1 oligonucleotide with the cRNA for
I1G1(M) or GIRK2wv had little effect on the
inhibition produced by 100 µM QX-314 for I1G1(M) plus KHAI (0.42 ± 0.04; N = 3) and for GIRK2wv
plus KHAI (0.46 ± 0.22; N = 13). Thus, the local
anesthetic binding site in I1G1(M) appears to be similar to that in
GIRK2wv channels.
|
To characterize the QX-314 binding site in more detail, the current
inhibition was examined at different concentrations of QX-314 and at
different voltages. Macroscopic currents were elicited by voltage steps
from +50 to
140 mV in the absence and then presence of 500 µM
QX-314 (Fig. 3). Voltage steps lasted
3-4 s to ensure that inhibition reached equilibrium. Heteromultimers
composed of GIRK1 and GIRK4 subunits were insensitive to extracellular QX-314 (Fig. 3 A). By contrast, the extent of current
inhibition increased with negative membrane potentials between
20 and
100 mV for I1G1(M) and GIRK2wv channels (Fig.
3, B and C). At membrane potentials more negative than
100 mV, the inhibition by 500 µM QX-314 became less
pronounced, suggesting that there was some relief of inhibition at very
negative membrane potentials. This relief of inhibition could be due to QX-314 exiting into the cytoplasm at strong hyperpolarizing membrane potentials.
|
To compare the sensitivity and the voltage dependence of QX-314
inhibition, the steady-state current at the end of the voltage step was
divided by the current in the absence of QX-314
(I/I0) and plotted as a
function of QX-314 concentration (Fig. 4,
A and C). The normalized data for each voltage
were fit with the Hill equation (Eq.1, see Materials and Methods). For
both channels, the Ki decreased with
hyperpolarization and the Hill coefficient was at or slightly below
unity (see Fig. 4 legend). The Ki was plotted as function of voltage to measure the voltage dependence (
)
of QX-314 inhibition (Fig. 4, B and D). The data
points were fit with the Woodhull equation (Eq. 3), which relates the
inhibition at a single site within the membrane to an equivalent
electrical distance (Woodhull, 1973
). The inhibition produced by QX-314
was strongly voltage dependent for both I1G1(M) and
GIRK2wv channels, having a
of 0.56 and 0.76 for I1G1(M) and GIRK2wv channels, respectively.
The exponential fits were limited to voltages over which the relief
from QX-314 inhibition (i.e., QX-314 exiting into the cytoplasm)
appeared negligible. Although both channels lose
K+ selectivity presumably through different
mechanisms, the binding site for QX-314 appears to be remarkably alike.
|
Inhibition of I1G1(M) and GIRK2wv by extracellular Ba2+
To elucidate possible differences in the pore structure between
GIRK2wv and I1G1(M), the sensitivity to
inhibition by extracellular Ba2+ was examined.
Current through heteromultimers composed of GIRK1 and GIRK4 subunits
was nearly completely inhibited by 500 µM Ba2+
(Fig. 5 A). As shown
previously, GIRK2wv channels were also inhibited
by 500 µM extracellular Ba2+ (Fig. 5
C) but slightly less than the inhibition of GIRK1-GIRK4 (Fig. 5 A) or GIRK1-GIRK2 heteromultimers (Slesinger et al.,
1997
). Surprisingly, I1G1(M) channels exhibited dramatically reduced inhibition with extracellular 500 µM Ba2+ at
membrane potentials between
10 and
100 mV (Fig. 5 B). To quantify these differences in Ba2+ sensitivity,
the steady-state current in the presence of Ba2+
was divided by the control current
(I/Io) and plotted as a
function of Ba2+ concentration. The data points
were fit with the Hill equation (Eq. 1) to determine the
Ki and Hill coefficient.
GIRK2wv channels were less sensitive to
inhibition by extracellular Ba2+ than
heteromultimers composed of GIRK1 and GIRK4 (Ki = 234 ± 42 µM for GIRK2wv versus 61 ± 20 µM for GIRK1-GIRK4 heteromultimer). By contrast, I1G1(M) showed
little inhibition with 3 mM Ba2+ and had an
extrapolated Ki of ~50 mM
Ba2+. Similar to the inhibition by QX-314,
co-expression of the KHA1 oligonucleotide had little effect on the
inhibition produced by Ba2+. These results
suggests that pore structure of GIRK2wv channels
is not identical to that of I1G1(M), even though both channels lose
K+ selectivity and have similar local anesthetic
binding sites.
|
The remaining experiments focused on the QX-314 inhibition of I1G1(M)
channels because GIRK2wv channels were toxic to
oocytes (Slesinger et al., 1996
; Tucker et al., 1996
) and
appeared functionally similar to I1G1(M) channels.
Time course of inhibition by extracellular QX-314
To examine the onset of inhibition in more detail, the inward current through I1G1(M) channels was recorded in the absence and then presence of different concentrations of extracellular QX-314 (Fig. 6 A). The current in the presence of QX-314 was divided by the control current (Fig. 6 B, inset) and was fit best with a sum of two exponentials. The presence of two time constants suggests that more than one binding site exists for QX-314. Both time constants decreased with more negative membrane potentials (Fig. 6 B), consistent with the voltage-dependent inhibition measured from steady-state inhibition (Fig. 4). In addition, both time constants decreased with higher concentrations of extracellular QX-314 (Fig. 6 B). Thus, the inhibition of I1G1(M) by QX-314 is a bimolecular reaction that is governed by voltage and concentration.
|
To determine whether the permeant ion had any effect on the rate of
inhibition, as has been shown for inhibition by external Ba2+ (Hurst et al., 1995
), the rate of QX-314
inhibition was measured in 15 mM extracellular KCl. Because
Na+ permeates I1G1(M), an equimolar concentration
of NMDG was substituted for KCl. In 15 mM KCl, the reversal potential
shifted to negative voltages and the current amplitude decreased (Fig.
6 C). The rate of inhibition followed a double-exponential
time course with time constants that were indistinguishable from those
obtained in 95 mM KCl (Fig. 6 D). Moreover, the voltage
dependence of the fast and slow time constants were similar in 15 and
95 mM KCl. These results suggest that QX-314 inhibition does not depend
on V-EK and that
K+ does not compete directly for QX-314 binding
in the pore.
If voltage drives the permanently charged QX-314 directly into the
pore, then the recovery from inhibition would be expected to be voltage
dependent. A standard two-pulse protocol, commonly used to examine the
voltage dependence of channel inactivation, was used to study the rate
of recovery from QX-314 inhibition (Fig. 6, E and
F). In this voltage protocol, the membrane potential was
changed from 0 mV to
80 mV for 3 s (first pulse) to induce QX-314 inhibition, was returned to 0 mV for varying lengths of time to
allow for recovery, and was then changed to
80 mV for a second time
to assess the extent of recovery. With increasingly longer times
separating the two voltage pulses, the peak current recovered to
control levels (Fig. 6, E and F). The recovery of the inhibited current was plotted as a function of the time interval (Fig. 6 E). With a 3-4-s interval the current recovered to
nearly 100% of control. The time course of recovery followed a
single-exponential time course at
40 mV, where channels remain
partially inhibited, and a double-exponential time course at 0 and +40
mV (Fig. 6 F). The rate of recovery at +40 mV was faster
than that at
40 mV suggesting that QK-314 preferentially exists
extracellularly. The voltage and concentration dependence of the onset
and recovery rates of inhibition suggest that QX-314 binds to
sites in the permeation pathway.
Mutations in pore-loop complex of I1G1(M) partially restore K+ selectivity and reduce QX-314 inhibition
Chimera I1G2(M), which contains the hydrophobic domains
(M1-pore-loop-complex-M2) from GIRK2, formed functional
K+ selective channels in Xenopus
oocytes (Fig. 1 D). The loss of K+
selectivity in I1G1(M) channels might be therefore caused by amino
acids that are unique to GIRK1. A comparison of the amino acid sequence
in the pore-loop complex of different GIRK channel subunits (Fig.
7 A) revealed two amino acids,
F137 and A142, that are unique to GIRK1. These two amino acids were
mutated to the corresponding amino acid in GIRK2. I1G1(M) channels
containing either an F137S or an A142T mutation displayed significantly
smaller currents in 95 mM Na+ (Fig. 7,
C and D). The
INa/IK
ratio was ~0.4 and ~0.55 for I1G1(M)-F137S and I1G1(M)-A142T,
respectively, as compared with 0.8 for I1G1(M) (Fig. 7 E).
In addition, I1G1(M)-F137S and I1G1(M)-A142T both exhibited
statistically significant smaller
PNa/PK
permeability ratios (Fig. 7 G). Chimera I1G1(M) containing
both mutations (F137S/A142T) showed tiny Na+
currents and a
PNa/PK
of 0.14 ± 0.04 (Fig. 7, E-G), as compared with a
PNa/PK
of 0.05 for GIRK1 and GIRK2 (Kofuji et al., 1996b
). These changes in
selectivity and Na+ current suggest that F137 and
A142 in the pore-loop of I1G1(M) altered the K+
selectivity.
|
If K+ selectivity is nearly completely restored by mutating two amino acids in the pore-loop of I1G1(M), then the inhibition produced by extracellular local anesthetics might be impaired. To test this hypothesis, the effects of 500 µM QX-314, QX-222, and lidocaine on the mutant I1G1(M) channels were examined (Fig. 8). Whereas QX-314 inhibited >80% of the current through I1G1(M) channels, QX-314 reduced the current by only 30% and 60% for I1G1(M)-F137S and I1G1(M)-A142T, respectively. I1G1(M)-F137S and I1G1(M)-A142T channels also showed significantly less inhibition by extracellular QX-222 than I1G1(M) (20% vs. 60%). More importantly, the K+-selective I1G1(M)-F137S/A142T double mutant was insensitive to extracellular local anesthetics (Fig. 8, D and E), similar to wild-type channels. Thus, the inhibition produced by local anesthetics decreased as the K+ selectivity improved, indicating that the inhibition by extracellular QX-314 is tightly linked to K+ selectivity.
|
Alanine substitution in the M2 transmembrane domain of I1G1(M)
The strong voltage dependence of QX-314 inhibition indicates that
QX-314 moves ~60% within the electric field, where it could potentially interact with amino acids in the M2 transmembrane domain.
The M2 transmembrane domain forms part of the inner vestibule of inward
rectifiers (Lu and MacKinnon, 1994
; Reuveny et al., 1996
; Stanfield et
al., 1994
). In addition, mutagenesis studies of voltage-gated
Na+ channels have localized the local anesthetic
binding site to the S6 transmembrane domain (Ragsdale et al., 1996
;
Sunami et al., 1997
), which is homologous to M2 transmembrane domain in GIRK channels. Thus, the M2 transmembrane domain in I1G1(M) might serve
as part of the local anesthetic binding site.
To examine this possibility, each amino acid in the M2 transmembrane domain of I1G1(M) was mutated individually to alanine and examined for a change in the sensitivity to the inhibition produced by extracellular QX-314. The apparent Ki was estimated using a form of the Hill equation (Eq.2, see Materials and Methods). For comparison among different batches of oocytes, the Ki for each mutant channel was normalized to the Ki for I1G1(M) channels that were expressed in the same batch of oocytes (Table 1). Five mutations in I1G1(M) (G158A, I159A, L163A, L168A, and I177A) decreased significantly (approximately twofold) the sensitivity to inhibition by QX-314. By contrast, six mutations (F162A, Q165A, I167A, G169A, I171A, and G178A) increased significantly the sensitivity to inhibition by extracellular QX-314 nearly twofold (Table 1). Interestingly, the elimination of the negative charge at D173 had no effect on QX-314 inhibition (Table 1).
|
Inhibition of I1G1(M) by intracellular QX-314
Intracellular application of QX-314 inhibits neuronal
G-protein-sensitive inwardly rectifying K+
currents (Alreja and Aghajanian, 1994
; Andrade, 1991
; Nathan et al.,
1990
; Otis et al., 1993
; Yamada et al., 1999
). The effect of
intracellular QX-314 on cloned GIRK channels has not been studied extensively. To examine the possible inhibition by intracellular QX-314, carbachol-induced currents were recorded first, QX-314 was then
injected directly into oocytes, and carbachol-induced currents were
recorded from the same oocyte for a second time. Based on a volume of
~1 µl (Sunami et al., 1997
), a 32.2-nl injection of 40 mM QX-314
would produce a final concentration of ~1250 µM. Intracellular
QX-314 reduced the early component of the carbachol-induced current (at
80 mV) by ~75% (Fig. 9, C
and D). The same concentration of QX-314, however, inhibited
only ~20% of the current through chimera I1G1(M) (Fig. 9,
A and D), a nearly fourfold change in sensitivity. By contrast, 1250 µM of extracellular QX-314 would be
expected to inhibit >90% of the current through I1G1(M) channels (Fig. 2). The K+-selective, double mutant
I1G1(M)-F137S/A142T also showed little inhibition with intracellular
QX-314 (Fig. 9, B and D). These results suggest
that the local anesthetic binding site in I1G1(M) is inaccessible from
the cytoplasmic side of the membrane.
|
| |
DISCUSSION |
|---|
|
|
|---|
There are three main findings in this paper. First, chimera I1G1(M) unexpectedly loses K+ selectivity, although there are no mutations in the chimera sequence. Second, the loss of K+ selectivity in I1G1(M) occurs coincidentally with an acquired sensitivity to inhibition by extracellular QX-314. Mutations that restore K+ selectivity in I1G1(M) eliminate the inhibition by extracellular QX-314. Third, the inhibition of wild-type GIRK channels by intracellular QX-314 appears to be different from that produced by extracellular QX-314 in nonselective GIRK channels. The results are discussed in terms of a model in which the pore-loop complex must be properly positioned to maintain high K+ selectivity and prevent large cations from reaching an intrapore binding site.
Loss of ion selectivity in chimera I1G1(M) caused by amino acids in the pore-loop complex
Both I1G1(M) and GIRK2wv channels lose the
ability to discriminate among K+ and
Na+ ions when expressed in Xenopus
oocytes. In GIRK2wv, a G156S mutation exists in
the GYG sequence of the pore-loop complex (Patil et al., 1995
), a
region that is highly conserved among all K+
channels and is critical for maintaining high K+
selectivity (Heginbotham et al., 1994
; Slesinger et al., 1996
). The
loss of K+ selectivity in chimera I1G1(M),
however, was unexpected because I1G1(M) does not contain site-specific
mutations in the pore-loop complex or anywhere else in the channel.
There are several plausible explanations for the loss of
K+ selectivity in I1G1(M).
First, the loss of K+ selectivity could arise
from the co-assembly of I1G1(M) with XIR, the endogenous GIRK subunit
in oocytes. This explanation is unlikely because co-injecting the cRNA
for I1G1(M) with an oligonucleotide that is antisense to XIR did not prevent the expression of inwardly rectifying Na-permeable and QX-314-sensitive ion channels (Hedin et al., 1996
). Moreover, expression of I1G1(M) yielded large currents, unlike the small currents
recorded from oocytes injected with the cRNA for GIRK1 (Hedin et al.,
1996
). A second possible explanation is that the N- and C-terminal
domains of IRK1 are incompatible with the hydrophobic core domains of
GIRK1 in I1G1(M). The loss of K+ selectivity in
I1G1(M) channels, however, was not associated with a large change in
the inward rectification, suggesting that these regions changed little
in I1G1(M).
A more likely explanation for the loss of K+
selectivity in I1G1(M) is that the combination of four identical
pore-loop complexes from GIRK1 is incompatible with high
K+ selectivity. First, Silverman et al. (1998)
reported that a GIRK4 chimeric channel containing the pore-loop complex
from GIRK1 was permeable to Na+, like I1G1(M).
Second, a chimera composed of GIRK2 in the core region, I1G2(M), was
shown to be K+ selective in this paper. Third,
mutations of two amino acids that are unique to GIRK1 (F137 and A142)
dramatically improved the K+ selectivity of
I1G1(M) when mutated to the homologous amino acids in GIRK2. The F137S
mutation in GIRK1, in particular, was implicated previously in the slow
activation kinetics and heteromeric assembly of GIRK channels in
Xenopus oocytes (Chan et al., 1996
; Kofuji et al., 1996a
).
Chan et al. (1996)
also found that GIRK1-F137S could express on the
surface of oocytes as a homomultimer. At present, the mechanism by
which a serine substitution in the pore-loop complex alters these
properties of GIRK channels is not well understood.
Assuming that the pore structure of GIRK channels is similar to that of
the bacterial K+ channel, KcsA, the homologous
amino acids (S69 and T74 in KcsA) in the pore-loop helix are positioned
where they can potentially affect K+ selectivity
(Fig. 7 A). In KcsA, S69 is buried in the protein core
between the pore-loop helix and the M1 and M2 transmembrane domains and
contacts the main-chain carbonyl oxygens and side chains of L40 and S44
of M1 and partly V95 of M2. The bulkier phenylalanine could disrupt the
packing of the protein, producing a large change in the backbone
carbonyl oxygens in the GYG sequence, which must be positioned
accurately to favor stabilizing unhydrated K+
ions versus smaller unhydrated Na+ ions (Doyle et
al., 1998
). The shift in the GYG must be large enough (~10 Å) to
allow QX-314 to reach the intrapore binding site. The T74 in KcsA, on
the other hand, faces the pore and may be involved in inhibition by
Ba2+ (Doyle et al., 1998
). The weak inhibition of
I1G1(M) by extracellular Ba2+ might be due to the
presence of an alanine at position 142, as compared with the more
Ba2+-sensitive GIRK2wv,
which has a threonine at the homologous position. That A142T must be
combined with F137S to restore K+ selectivity in
I1G1(M) suggests that the bulkier threonine is structurally more
compatible than alanine for maintaining K+ selectivity.
An intrapore binding site for extracellular QX-314 in nonselective GIRK channels
The second main finding in this paper is that nonselective GIRK
channels, in general, appear to be sensitive to inhibition by
extracellular QX-314. The most parsimonious explanation for the
acquired sensitivity is that GIRK channels possess an intrapore binding
site that is normally inaccessible to permanently charged local
anesthetics applied from the extracellular side of the membrane. If we
suppose that a loss of ion selectivity occurs when the position of the
critical GYG in the pore-loop complex is altered, then permanently
charged local anesthetics could move past the misaligned selectivity
filter to a binding site deep within the pore. Consistent with this
conclusion, the mutations in the pore-loop helix that restored
K+ selectivity also dramatically reduced the
inhibition produced by all three local anesthetics. The selectivity
filter of Na+ channels may serve a similar role.
Sunami et al. (1997)
reported that mutations in the selectivity filter
of skeletal muscle Na+ channels exposed an
intrapore binding site for QX-314. Similarly, Adams et al. (1999)
recently reported that a mutation in the pore-loop complex of a
Na+ channel altered Na+
selectivity and revealed a voltage-dependent inhibition by
extracellularly applied tetraethylammonium (TEA). Thus, by virtue of
the strong ion selectivity in these ion channels, the selectivity
filter also prevents large, charged cations from reaching the central pore cavity.
Although the mechanism underlying the change in ion selectivity in
I1G1(M) and GIRK2wv is likely different, both
channels are inhibited by extracellularly applied local anesthetics.
Most parameters of QX-314 inhibition (e.g.,
Ki(0), Hill coefficient, voltage
dependence, and rank order sensitivity to inhibition by QX-222, QX-314,
or lidocaine) were indistinguishable between I1G1(M) and
GIRK2wv, suggesting that the local anesthetic
binding sites in GIRK1 and GIRK2 are similar. Like
GIRK2wv, GIRK4 channels containing the
weaver mutation also lose K+
selectivity and become sensitive to inhibition by extracellular QX-314
(Silverman et al., 1996
). The sensitivity to inhibition by
extracellular QX-314 may be a general feature of nonselective GIRK channels.
The voltage dependence of QX-314 inhibition indicates that QX-314 binds
to a site within the pore that senses more than half the electric
potential drop across the membrane. In voltage-gated K+ channels, the majority of the voltage drop
occurs across the pore-loop complex (Yellen et al., 1991
). Thus, QX-314
likely moves to a site deep within the pore, just cytoplasmic to the
pore-loop complex. In fact, the upper half of the M2 transmembrane
domain may comprise part of the binding site for QX-314. Of the 21 alanine substitutions studied in I1G1(M), 11 significantly shifted the sensitivity to inhibition by QX-314 by approximately ±0.4 kcal/mol (
G). These 
G values are comparable to
those (0.4-1.9 kcal/mol) reported for changes in QX-314 inhibition
that were produced by mutations in the S6 transmembrane domain of
voltage-gated Na+ channels (Ragsdale et al.,
1996
; Sunami et al., 1997
). In Ca2+ channels,
alanine substitutions in the S6 transmembrane domain produced
0.4-0.94-kcal/mol changes in the sensitivity to diltiazem inhibition
(Kraus et al., 1998
). Different types of amino acid substitutions in
the M2 of I1G1(M) might result in larger 
G values.
When arranged into an
-helix, six of the amino acids that shifted
the sensitivity of QX-314 inhibition (G158, I159, F162, Q165, G169, and
I177) cluster along one face of the helix. Based on studies that have
systematically mutated the M2 transmembrane domain of inwardly
rectifying K+ channels (Choe et al., 1995
;
Collins et al., 1997
; Loussouarn et al., 2000
; Lu et al., 1999
), L163,
Q165, G169, and I177 would be expected to face the pore and are in a
good position to affect QX-314 binding. In the model proposed by Minor
et al. (1999)
, four of the amino acids (G158, F162, Q165, and G169)
would be at M1-M2 helix contact points and three would face the pore
(K159, L163, and I177). The majority of the pore-facing amino acids
that changed QX-314 were hydrophobic, suggesting that the
dimethylphenyl moiety of QX-314 might interact preferentially with
I1G1(M). Using the KcsA structure as a model for inward rectifiers, the
internal pore of a GIRK channel is likely a water-filled cavity lined
with hydrophobic amino acids, which is large enough (10 Å) to
accommodate either TEA or QX-314 (Doyle et al., 1998
). In fact, both
TEA and QX-314 bind to an intrapore binding site in voltage-gated
K+ channels (Baukrowitz and Yellen, 1996
). The
hydrophobic environment of the intrapore cavity of GIRK channels may
therefore comprise the binding site for QX-314.
Comparison with inhibition by intracellular QX-314
In neurons (Andrade, 1991
; Lambert and Wilson, 1993
; Yamada et
al., 1999
) and Xenopus oocytes (this study), activation of GIRK currents is inhibited by high concentrations of intracellular QX-314. I1G1(M) channels, however, showed fourfold less inhibition to
intracellular QX-314 than did wild-type GIRK channels. Even the
K+-selective I1G1(M)-F137S/A142T showed little
inhibition with intracellular QX-314, indicating that lack of
K+ selectivity in I1G1(M) did not account for the
change in sensitivity to intracellular QX-314. I1G1(M) channels are
constitutively active and no longer require G proteins (Slesinger et
al., 1995
). The lack of inhibition by intracellular QX-314 could be
therefore related to the loss of G-protein-gating in I1G1(M).
Consistent with this conclusion, a recent study with membrane-permeant
local anesthetics indicated that local anesthetics inhibit GIRK
channels but not other inwardly rectifying K+
channels by interfering with the gating underlying G protein or ethanol
activation of GIRK channels (Zhou and Slesinger, 2000
). The mechanism
underlying inhibition of nonselective GIRK channels with extracellular
QX-314, therefore, appears to be different from that governing
inhibition of wild-type GIRK channels with intracellular QX-314.
| |
ACKNOWLEDGMENTS |
|---|
I thank Christine Arrabit for assisting with the molecular biology, Chuck Stevens and Gary Yellen for comments, Senyon Choe for the KcsA picture, David Clapham for providing the GIRK4 cDNA, and Michel Lazdunski for providing the GIRK2 cDNA.
This work was made possible by financial support from the Alfred P. Sloan Foundation, the National Institutes of Health (NINDS), the McKnight Endowment Fund for Neuroscience, and the Fritz-Burns Foundation.
| |
FOOTNOTES |
|---|
Received for publication 8 June 2000 and in final form 7 November 2000.
Address reprint requests to Dr. Paul A. Slesinger, The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037. Tel.: 858-453-4100; Fax: 858-552-1546; E-mail: slesinger{at}salk.edu.
| |
REFERENCES |
|---|
|
|
|---|

to the GIRK1 G protein-gated inwardly rectifying K+ channel is important for channel activation.
Neuron.
15:1133-1143
directly binds to the carboxyl terminus of the G protein-gated muscarinic K+ channel, GIRK1.
Biochem. Biophys. Res. Commun.
212:1022-1028
subunits and function as heteromultimers.
Proc. Natl. Acad. Sci. USA.
92:6542-6546
binds directly to the G protein-gated K+ channel, IKACh.
J. Biol. Chem.
270:29059-29062
subunits.
Nature.
370:143-146
-aminobutyric acid type B receptor-activated inwardly rectifying K+ currents in cerebellar granule cells isolated from